XML 41 R31.htm IDEA: XBRL DOCUMENT v3.25.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration risks (Details)
1 Months Ended 3 Months Ended
May 14, 2025
Sep. 13, 2024
Apr. 30, 2025
Mar. 31, 2025
USD ($)
customer
Mar. 31, 2024
USD ($)
customer
Concentration risks          
Aggregate dollar amount of net sales       $ 8,295,173 $ 7,599,363
Syringes and needles | China          
Concentration risks          
Tariff percentage   100.00%      
Percentage increase in tariffs for syringes and needles   100.00%      
Syringes and needles | China | Subsequent Event          
Concentration risks          
Tariff percentage 130.00%        
Other products          
Concentration risks          
Aggregate dollar amount of net sales       $ 7,684 $ 7,979
Other products | China | Subsequent Event          
Concentration risks          
Tariff percentage 30.00%   145.00%    
Net Sales | Customer Concentration Risk          
Concentration risks          
Number of significant customers | customer       3 2
Net Sales | Customer Concentration Risk | Significant customers          
Concentration risks          
Aggregate dollar amount of net sales       $ 4,900,000 $ 3,400,000
Concentration risk, percentage       58.60% 44.30%
Cost of Sales, Manufacturing | Supplier Concentration Risk | China          
Concentration risks          
Concentration risk, percentage       62.70% 90.40%